Abstract
Parkinson's disease (PD) is a neurodegenerative disease, characterized in part by the loss of dopaminergic neurons in two parts of the brain - the substantia nigra and its projections into the striatum - causing various motor, cognitive and sensory deficits. Currently, the most used treatment is the administration of L-DOPA. However, this drug has limited efficacy and several side effects…